Compounds > hydroxyphenytoin
Page last updated: 2024-08-22

hydroxyphenytoin and warfarin

hydroxyphenytoin has been researched along with warfarin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gugler, R; Jensen, JC1
Gorman, LA; Kumar, V; Rock, DA; Tracy, TS; Wahlstrom, JL; Warren, CJ1
Mosher, CM; Rettie, AE; Tai, G1

Other Studies

3 other study(ies) available for hydroxyphenytoin and warfarin

ArticleYear
Omeprazole inhibits oxidative drug metabolism. Studies with diazepam and phenytoin in vivo and 7-ethoxycoumarin in vitro.
    Gastroenterology, 1985, Volume: 89, Issue:6

    Topics: Adult; Benzimidazoles; Coumarins; Diazepam; Drug Interactions; Humans; In Vitro Techniques; Kinetics; Male; Microsomes, Liver; Nordazepam; Omeprazole; Oxidation-Reduction; Phenytoin

1985
CYP2C9 inhibition: impact of probe selection and pharmacogenetics on in vitro inhibition profiles.
    Drug metabolism and disposition: the biological fate of chemicals, 2006, Volume: 34, Issue:12

    Topics: Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C9; Diclofenac; Enzyme Inhibitors; Flurbiprofen; Genotype; In Vitro Techniques; Pharmacogenetics; Phenytoin; Piroxicam; Tolbutamide; Warfarin

2006
CYP2C9 amino acid residues influencing phenytoin turnover and metabolite regio- and stereochemistry.
    The Journal of pharmacology and experimental therapeutics, 2009, Volume: 329, Issue:3

    Topics: Amino Acid Substitution; Amino Acids; Aryl Hydrocarbon Hydroxylases; Biocatalysis; Catalytic Domain; Cytochrome P-450 CYP2C9; Humans; Kinetics; Models, Molecular; Phenytoin; Recombinant Fusion Proteins; Stereoisomerism; Tandem Mass Spectrometry; Warfarin

2009